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Abstract
Background: The Paul Coverdell National Acute Stroke Registry (PCNASR) is a U.S. based
national registry designed to monitor and improve the quality of acute stroke care delivered by
hospitals. The registry monitors care through specific performance measures, the accuracy of
which depends in part on the reliability of the individual data elements used to construct them. This
study describes the inter-rater reliability of data elements collected in Michigan's state-based
prototype of the PCNASR.
Methods: Over a 6-month period, 15 hospitals participating in the Michigan PCNASR prototype
submitted data on 2566 acute stroke admissions. Trained hospital staff prospectively identified
acute stroke admissions, abstracted chart information, and submitted data to the registry. At each
hospital 8 randomly selected cases were re-abstracted by an experienced research nurse. Inter-
rater reliability was estimated by the kappa statistic for nominal variables, and intraclass correlation
coefficient (ICC) for ordinal and continuous variables. Factors that can negatively impact the kappa
statistic (i.e., trait prevalence and rater bias) were also evaluated.
Results: A total of 104 charts were available for re-abstraction. Excellent reliability (kappa or ICC
> 0.75) was observed for many registry variables including age, gender, black race, hemorrhagic
stroke, discharge medications, and modified Rankin Score. Agreement was at least moderate (i.e.,
0.75 > kappa ≥; 0.40) for ischemic stroke, TIA, white race, non-ambulance arrival, hospital transfer
and direct admit. However, several variables had poor reliability (kappa < 0.40) including stroke
onset time, stroke team consultation, time of initial brain imaging, and discharge destination. There
were marked systematic differences between hospital abstractors and the audit abstractor (i.e.,
rater bias) for many of the data elements recorded in the emergency department.
Conclusion: The excellent reliability of many of the data elements supports the use of the
PCNASR to monitor and improve care. However, the poor reliability for several variables,
particularly time-related events in the emergency department, indicates the need for concerted
efforts to improve the quality of data collection. Specific recommendations include improvements
to data definitions, abstractor training, and the development of ED-based real-time data collection
systems.
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Background
The Paul Coverdell National Acute Stroke Registry
(PCNASR) is a multi-state network of hospital-based reg-
istries whose primary objective is to establish a system for
monitoring and improving the quality of care provided to
acute stroke patients [1,2]. Between 2001 and 2004 the
PCNASR established prototype registries in eight states
including Michigan [3]. These prototypes reported gaps
between treatment guidelines and actual hospital care that
highlighted the need for quality improvement initiatives
[2,4,5].
Data from the PCNASR are used to construct specific per-
formance measures that measure the quality of care [6,7].
Like all registries the value of the PCNASR depends in part
upon the reliability of the data it collects, particularly
those data elements that are used to define performance
measures. Given that registry data are collected by multi-
ple abstractors at different hospitals, data quality is vul-
nerable to several sources of error including mistakes in
data interpretation and data entry [8]. The quality of reg-
istry data can be negatively influenced by several different
factors, including inadequate abstractor training and
monitoring, the use of ambiguous data definitions, and
differences in information accessibility i.e., missing med-
ical record data, or access to information sources outside
the medical record [9,10]. To minimize such errors and
enhance data reliability for the prototype registries, the
PCNASR expert panel developed a set of standardized
data elements and definitions [1,2]. Prototypes were also
encouraged to adopt standardized methods for promot-
ing the quality data, including training in chart abstrac-
tion, evaluation of case ascertainment, and assessment of
inter-rater reliability of collected data [11,12]. A previous
study reported on the results of a chart audit designed to
compare the completeness and accuracy of data collected
by prospective and retrospective prototypes of the
PCNASR [13]. This study found few differences between
prospective and retrospective prototypes, but found a
high percentage of missing information associated with
pre-hospital EMS data, thrombolytic treatment, and
stroke signs and symptoms. However, this study did not
examine the inter-rater reliability or agreement between
hospital abstractors and auditors for individual data ele-
ments. The objective of our study was therefore to assess
the inter-rater reliability of individual data elements in a
random sample of subjects from the Michigan registry
prototype.
Methods
Registry design
The MASCOTS (Michigan Acute Stroke Care Overview &
Treatment Surveillance System) registry was one of the
eight state-based prototype registries developed by the
PCNASR. Detailed descriptions of the MASCOTS registry
are available elsewhere [2,14]. In order to obtain a repre-
sentative sample of hospitals providing acute stroke care
in Michigan, the registry used a modified, stratified, sin-
gle-stage cluster design [15], to obtain a sample of 16 hos-
pitals. First, 8 hospitals were selected with certainty from
4 urban communities that were already participating in a
community-based stroke project. These hospitals repre-
sented larger academic and non-academic urban institu-
tions. Second, the remaining 114 acute care hospitals in
the state that provided care to > 30 stroke cases in year
2000 were ranked according to size, and four equal sized
strata created. Two hospitals were then randomly selected
from each of the 4 strata, resulting in a final sample of 16
hospitals. The 16 selected hospitals were responsible for
providing care to approximately 25% of stroke cases
statewide, and analysis of their size, geographical loca-
tion, teaching status, and county-level population demo-
graphics indicated that they were broadly representative
of all hospitals in the state [14].
On-site coordinators ascertained acute stroke admissions
using prospective methods. Between May and October
2002, the registry collected data on 2,566 confirmed acute
stroke admissions from 15 hospitals (one hospital closed
shortly after sampling). The MASCOTS project was
granted an expedited status by hospital institutional
review boards, because its primary purpose was quality
improvement and no direct patient contact was involved.
Data collection and quality control
The original PCNASR data elements included 63 core
items and 22 optional items organized into twelve sec-
tions with definitions for each item. A copy of the original
data elements (see Additional file 1: Original PCNASR
data elements_2002.pdf) and the most current version
[16] (see Additional file 2: Current PCNASR data
elements_2007.pdf) are available on-line. Chart abstrac-
tions were performed at each hospital by either the site
coordinator or a member of its quality improvement staff
(we refer to the hospital staff as hospital abstractors). Prior
to the start of the study, hospital abstractors attended a
day long training session that covered all data collection
steps including a detailed review of the data elements and
definitions. Throughout the data collection period,
project staff made regular site visits and provided supple-
mental training and technical support by telephone or e-
mail. Hospital abstractors collected data using either a
hand held computer (4 sites) or a paper abstraction tool
(11 sites). Data were then entered and stored on secure
desktop computers and transmitted to the central study
office every other week. Staff at the central study office
performed quality control using SAS software, Version 8.2
(SAS Institute Inc., Cary, NC, USA) to generate automated
discrepancy reports to identify missing or invalid
responses which were then sent back to the hospitalBMC Neurology 2008, 8:19 http://www.biomedcentral.com/1471-2377/8/19
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abstractors for resolution. Only missing data attributed to
being not documented in the medical record was consid-
ered valid. An abstracted record must have generated zero
discrepancies before being classified as "closed."
Audit sampling and chart re-abstraction
To evaluate the inter-rater reliability of the MASCOTS reg-
istry data, independent site audits were performed by a
research nurse (SW) with extensive experience in acute
stroke care and chart abstraction (we refer to this person
as the audit abstractor). The audit sampling procedure
randomly selected a block of eight sequential acute stroke
admissions from each of the 15 hospitals' suspect stroke
logbooks, resulting in 120 (8 × 15) chart re-abstractions.
The number of re-abstractions was based on a combina-
tion of practical concerns (the number of charts that could
be re-abstracted in a one-day site visit), as well as formal
sample size calculations for the kappa statistic [17]. Using
alpha and beta error rates of 0.05 and 0.2, respectively,
when testing for a statistical difference between moderate
(i.e., 0.40) and high (i.e., 0.75) kappa values, sample size
estimates ranged from 77 to 28 when the trait prevalence
was varied between 10% and 50%. Thus, the initial target
sample size of 120 provided ample power to detect clini-
cally important registry-level differences in reliability,
however, this study was not powered to examine hospital-
level differences.
To preserve the integrity of the audit, hospital abstractors
were blinded to both the sampling procedure and the
audit date. Of the 120 admissions, 3 were later deter-
mined to be non-stroke cases, and 13 did not have a chart
available during the audit visit, leaving a total of 104 con-
firmed acute stroke admissions that underwent chart re-
abstraction. This audit data was then compared to the
"closed" registry data.
Statistical analysis
Measures of inter-rater reliability were calculated for nom-
inal variables with at least 30 records, and continuous and
ordinal variables with at least 10 records. We included
time variables (formatted as the number of minutes past
midnight), but excluded dates and text data. For nominal
variables, we configured individual response options as
component dichotomies (positive or negative) [18]. For
example, race was analyzed on six separate component
dichotomies (white, black, Asian, American Indian, other,
and not documented). Variables with the response
options of 'No,' 'Unknown,' or 'Not documented' were
coded as negative – an approach consistent with docu-
mentation by exception. We calculated kappa statistics
and 95% lower confidence limits (95% LCL) as a measure
of inter-rater reliability that adjusts for chance agreement
[19]. To interpret kappa, we used criteria where a kappa ≥
0.4 suggests moderate agreement, and a kappa ≥ 0.75 sug-
gests excellent agreement.
Kappa works best when the positive and negative ratings
are balanced. However, when ratings are nearly all posi-
tive or all negative because the data is highly unbalanced,
kappa becomes highly sensitive to small departures from
perfect concordance [19,20]. To aid interpretation of
kappa, we therefore calculated measures of trait preva-
lence and rater bias [20]. To estimate the trait prevalence,
we used the prevalence index, PI = (a - d)/N, where a and
d are concordant ratings between the two raters and N is
the sum of all ratings [21]. The PI can take values from -1
to +1; it is zero when concordant ratings are balanced, -1
when a trait is always absent, and +1 when always present.
In this study, we used a PI < -0.90 or > 0.90 as criteria to
indicate that the data was unsuitable for the calculation of
kappa.
Rater bias occurs when there is a systematic difference
between raters in their tendency to make a particular rat-
ing. We estimated the extent to which the hospital abstrac-
tors systematically differed from the audit rater using the
bias index, BI = (b - c)/N, where b and c are discordant rat-
ings [21]. The BI can take values from -1 to +1, and is zero
when there is no bias. In this study, a positive BI indicates
a bias toward the hospital abstractors, and a negative BI
indicates a bias towards the audit abstractor. A BI < -0.10
or > 0.10 was used as criteria to indicate a substantial bias
effect.
To examine the inter-rater reliability of continuous and
ordinal variables, such as age or the modified Rankin
Scale (mRS), we calculated intraclass correlations (ICC)
using a 2-way, random effects ANOVA model [22]. The
interpretation of an ICC is similar to kappa. To show the
magnitude of disagreement and to test for bias, we calcu-
lated the mean and the standard deviation of the differ-
ence between the prototype and audit raters, and used the
T-test to determine statistical significance between means
[23].
Results
The demographic profile of the 104 study subjects was
almost identical to the overall MASCOTS registry of 2566
acute stroke admissions [2]. Based on the data collected
by the hospital abstractors, the mean age of the 104 audit
subjects was 70.9 years, 59% were female, and 77% were
white, 17% black, 1% other race, and 5% not docu-
mented. The distribution of stroke sub-types were 58%
ischemic stroke, 8% intracranial hemorrhage (ICH), 6%
subarachnoid hemorrhage (SAH), 17% TIA, and 11%
stroke of uncertain type.BMC Neurology 2008, 8:19 http://www.biomedcentral.com/1471-2377/8/19
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In this article, we report measures of agreement for key
demographic variables and those data elements that are
directly relevant to the calculation of the current set of
stroke performance measures [6,7]. Items with either a
very high or low prevalence index (i.e., PI < -0.90 or >
0.90) or those that did not meet the minimal sample size
requirements are not presented (results for the full set of
data elements are available on-line (see Additional file 3:
Inter-rater reliability_PCNASR data elements_all.pdf).
Table 1 shows the inter-rater reliability kappa estimates
for nominal data related to stroke sub-type, gender, race,
health insurance and arrival mode. Agreement was excel-
lent (i.e., kappa ≥ 0.75) for hemorrhagic stroke sub-types
(i.e., ICH and SAH), gender, black race, Medicare insur-
ance, and ambulance arrival. Agreement was at least mod-
erate (kappa ≥ 0.40) for ischemic stroke, TIA, white race,
Medicaid or self-pay, non-ambulance arrival, hospital
transfer and direct admit. Using the criteria of a bias index
(BI) of < -0.10 or > 0.10 to indicate a substantial bias
effect, there was a substantial systematic differences
between hospital abstractors and the audit abstractor for
the recording of white race, and race not documented
(Table 1). The positive BI for white race (BI = 0.13) indi-
cates that the hospital abstractors were more likely to
mark this option compared to the audit rater, while the
negative BI for race not documented (BI = -0.11) illus-
trates the concomitant tendency for the audit rater to
record race as not documented. As expected, both of these
items were associated with reduced kappa values. Table 2
presents the intraclass correlations (ICC) and measures of
bias for selected continuous and ordinal variables. All var-
iables, including age were recorded with very high reliabil-
ity (ICC ≥ 0.80).
Table 3 shows the estimates of inter-rater reliability for
nominal data related to the emergency department (ED)
processes relevant to the decision to treat a patient with
tissue plasminogen activator (tPA). These data include the
documentation (i.e., presence or absence) of critical time
points such as stroke onset time, ED arrival time, time first
seen by a doctor, time of stroke team consult, and time of
initial brain imaging. Only 2 items had excellent agree-
ment (i.e., kappa ≥ 0.75): the presence of hemorrhage on
initial brain image, and whether time (i.e., > 3 hours) was
the reason that tPA was not given (Table 3). Several
important variables had poor agreement (kappa < 0.40)
including whether a stroke team was consulted, whether
the time of the stroke team consultation was documented,
and whether the time of initial brain imaging was docu-
mented. Data items relevant to understanding the onset of
stroke symptoms showed only moderate reliability at
best; whether the onset of symptoms was specific (i.e.,
known precisely) or estimated (i.e., identified as occurring
within a 6 hour window) showed moderate (kappa 0.51)
and poor (kappa 0.22) reliability, respectively. Finally, the
source of the onset time information (i.e., witnessed,
patient self report or not documented) were all unreliable
measures (kappa < 0.40). Most of the items shown in
Table 3 had BIs that exceeded ± 0.10 indicating substantial
systematic differences between hospital abstractors and
the audit rater. For example, documentation that the date
and time of stroke team consult was missing (non-docu-
Table 1: Inter-rater reliability for stroke sub-type, demographic, clinical features, and pre-hospital data.
Variable (Item Number) Dichotomous response option N PI* Kappa (95% LCL)† BI‡
Coverdell stroke sub-type (1.0) Ischemic Stroke 104 0.24 0.61 (0.46) -0.07
Intracranial hemorrhage (ICH) 104 -0.86 0.93 (0.79) 0.01
Subarachnoid hemorrhage (SAH) 104 -0.89 0.90 (0.72) 0.01
Transient ischemic attack (TIA) 104 -0.64 0.70 (0.52) -0.01
Gender (1.2) Female 104 0.16 0.98 (0.94) 0.01
Race (1.3) White 104 0.40 0.55 (0.38) 0.13
Black or African American 104 -0.66 0.97 (0.90) 0.01
Not documented (missing) 104 -0.76 0.07 (-0.13) -0.11
Health Insurance status (1.7) Medicare 104 0.43 0.83 (0.72) 0.03
Medicaid 104 -0.86 0.50 (0.18) - 0.03
Self-pay 104 -0.89 0.52 (0.15) 0.01
Arrival mode (2.2) Ambulance 104 -0.40 0.82 (0.69) 0.00
Other 104 -0.14 0.59 (0.43) -0.01
Hospital transfer 104 -0.74 0.70 (0.50) 0.03
Not documented (missing) 104 -0.72 0.40 (0.15) -0.01
Direct admit (2.2b) Yes 98 -0.88 0.47 (0.17) 0.04
* Prevalence Index (PI) is a measure of the true prevalence of the trait. PI is 0 when concordant responses are equally balanced between the 2 
raters. A large negative PI indicates trait is rarely found, while a large positive PI indicates trait is common. Variables with extreme distributions i.e., 
PI < -0.90 or > 0.90 are not shown. † 95% LCL = 95% Lower Confidence Limit.
‡ Bias Index (BI) is a measure of the relative bias between the hospital and audit abstractors. BI is 0 when there is no bias. Positive BI values indicate 
a bias toward the hospital abstractor, negative BI values indicates a bias towards the audit abstracter. BI values > 0.10 or < -0.10 indicate substantial 
bias.BMC Neurology 2008, 8:19 http://www.biomedcentral.com/1471-2377/8/19
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mented) had a strong positive bias (BI = 0.40), indicating
the tendency for the hospital abstractors to record this
item as missing, while the audit abstractor tended to
record a time for this item. Another example of strong
rater bias was whether the source of information on stroke
onset time was documented or not. This item was associ-
ated with a large negative bias (BI = -0.74) indicating that
the audit abstractor had a much stronger tendency to
record this item as missing, as compared to the hospital
abstractors (Table 3). It is important to note that when
both hospital and audit abstractors did record a date and
time for the ED-based processes, the results were very reli-
able as indicated by the high ICC results (i.e., 0.87 – 0.99)
for stroke onset time, ED arrival time, time first seen by a
doctor, and time of initial brain imaging (Table 2).
The inter-rater reliability of data related to medical his-
tory, and in-hospital diagnostic procedures and treat-
ments are shown in Table 4. Most of the medical history
items were recorded with good to excellent agreement
(i.e., kappa values > 0.70), while stroke/TIA, coronary
heart disease (CAD), and smoking were moderately relia-
ble (i.e., kappa values 0.59–0.62). In-hospital procedures
such as the identification of atrial fibrillation (AF) in the
hospital, anti-thrombotic treatment within 24 hours of
admission, and screening for dysphagia were also moder-
ately reliable (i.e., kappa 0.55 – 0.64). Only DVT prophy-
laxis showed a substantial bias effect (BI = 0.11)
indicating the tendency for the hospital abstractor to more
frequently record this intervention as having occurred,
compared to the audit rater. Blood lipid measures i.e.,
Table 2: Intraclass correlations (ICC) and measures of bias for selected continuous and ordinal variables.
Difference between ratings†
Variable (units) (Item Number) N* ICC (95% LCL) Mean SD‡ P
Age (years) (1.1) 104 0.98 (0.96) -0.11 3.19 0.957
Stroke onset time (mins) (6.2) § 19 0.99 (0.99) -10.00 29.72 0.903
ED arrival time (mins) (4.1) 78 0.87 (0.82) 16.55 168.07 0.775
Time first seen by doctor (mins) (4.2) 49 0.88 (0.82) 22.14 160.26 0.770
Initial brain imaging time (mins) (5.2) 30 0.93 (0.89) -19.97 111.67 0.809
Total Cholesterol (mg/dL) (12.9) 35 0.91 (0.86) 4.29 22.03 0.705
HDL (mg/dL) (12.9) 33 0.99 (0.99) 0.33 1.34 0.916
LDL (mg/dL) (12.9) 28 1.00 0.00 0.00 1.000
Modified Rankin at discharge (Score) (12.6) 99 0.80 (0.73) -0.01 1.10 0.968
*Where both prototype and audit data have values. †Calculated as audit abstractor minus hospital abstractor. ‡Standard deviation of the difference. 
§Where both auditor and prototype raters recorded onset time as specific. 95% LCL = 95% Lower Confidence Limit. P = T-test probability.
Table 3: Inter-rater reliability for Emergency Department (ED) evaluation, imaging, stroke onset time, and t-PA related data.
Variable (Item Number) Dichotomous response option N PI* Kappa (95% LCL)† BI‡
Date & time ED arrival (4.1) Not documented (missing) 90 0.63 0.59 (0.40) 0.07
Date & time first seen by doctor (4.2) Not documented (missing) 90 0.21 0.44 (0.26) 0.04
Stroke team consult (4.3) Yes 90 -0.12 0.30 (0.10) 0.01
Date & time stroke team consult (4.1) Not documented (missing) 40 0.20 0.02 (-0.20) 0.40
Stroke/TIA diagnosed in ED (4.6) Yes 90 0.86 0.26 (-0.08) 0.03
Type of initial brain image (5.1) CT 104 0.89 0.71 (0.41) -0.03
Date & time initial brain image (5.2) Not documented (missing) 104 -0.08 0.32 (0.15) 0.17
Date & time image results first known (5.5) Not documented (missing) 103 -0.46 0.25 (0.10) 0.29
Intracranial hemorrhage on image (5.6) Yes 103 -0.71 0.84 (0.70) 0.00
Stroke onset time documented (6.1) Yes – Specific time 104 -0.40 0.51 (0.33) 0.13
Yes – Estimated time 104 -0.17 0.22 (0.06) -0.25
No 104 -0.44 0.48 (0.30) 0.12
Source of onset time data if specific (6.2b) Witnessed 38 -0.37 0.21 (-0.05) 0.26
Patient self-report 38 -0.45 0.06 (-0.11) 0.39
Not documented (missing) 38 -0.26 0.00 -0.74
Reasons for non-treatment with tPA (8.1) Time 86 -0.83 0.78 (0.54) 0.03
Not documented (missing) 86 0.59 0.54 (0.33) -0.10
* PI = Prevalence Index (see Table 1 footnote for interpretation).
† 95% LCL = 95% Lower Confidence Limit.
‡ BI = Bias Index (see Table 1 footnote for interpretation).
ED = Emergency department, CT = computer tomography, tPA = tissue plasminogen activator (thrombolysis treatment)BMC Neurology 2008, 8:19 http://www.biomedcentral.com/1471-2377/8/19
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total cholesterol, LDL-cholesterol showed excellent relia-
bility and no evidence of statistically significant bias
(Table 2).
Medications used at discharge were recorded with excel-
lent agreement (Kappa > 0.75) (Table 5), however, dis-
charge destination, specifically whether discharge home
or to a skilled nursing facility both showed surprisingly
poor reliability (i.e., kappa < 0.4) and high positive bias
(BI > 0.10) indicating the tendency for the hospital
abstractors to record these events as occurring compared
to the audit rater. Ambulatory status at discharge was
moderately reliable when recorded as either able or una-
ble to ambulate, but the middle category (subject requires
assistance to ambulate) showed poor reliability (kappa
0.19). The modified Rankin score (MRS) showed excellent
agreement (ICC 0.80) and no evidence for statistically sig-
nificant rater bias (Table 2).
Discussion
The use of performance measures to measure the quality
of patient care is the primary mechanism by which
improvements to the quality of acute stroke care can be
made on a system wide basis [1,2,24]. However, for this
approach to be successful it is vital that the data from
which performance measures are constructed be reliable.
We examined the inter-rater reliability of individual data
elements in the PCNASR, and found that while most of
them had moderate to excellent inter-rater reliability,
some measures, especially ED-based time variables (i.e.,
time of stroke onset, stroke team consultation and brain
imaging), showed poor reliability. Time related events are
particularly important for stroke care because available
acute therapy, for example intravenous tPA, requires
administration within 3 hours of symptom onset [25].
The most common problem affecting these data elements
was the large amount of missing data; data was recorded
by both abstractors in only a minority of subjects. For
example, a specific stroke onset time was recorded by both
the hospital abstractor and audit abstractor in only 18%
Table 4: Inter-rater reliability for medical history, and select in-hospital diagnostic procedures, and treatments.
Variable (Item Number) Dichotomous response option N PI* Kappa (95% LCL)† BI‡
Past Medical History (9.1) Stroke/TIA 104 -0.23 0.59 (0.44) -0.04
Myocardial infarction 104 -0.71 0.77 (0.59) 0.02
CAD 104 -0.26 0.61 (0.45) -0.05
AF 104 -0.64 0.70 (0.52) 0.01
Hypertension 104 0.38 0.73 (0.59) 0.04
Dyslipidemia 104 -0.40 0.72 (0.58) 0.04
Diabetes 104 -0.48 0.80 (0.67) 0.04
Smoking 104 -0.59 0.62 (0.43) 0.03
AF present in hospital (10.1) Yes 104 0.63 0.59 (0.40) 0.07
Anti-thrombotic therapy initiated (10.4) Within 24 hours 104 0.53 0.55 (0.37) 0.09
DVT prophylaxis initiated (10.6) Within 48 hours 104 -0.49 0.43 (0.24) 0.11
Screening for dysphagia (10.7) Yes 104 -0.32 0.64 (0.48) 0.05
* PI = Prevalence Index (see Table 1 footnote for interpretation). † 95% LCL = 95% Lower Confidence Limit. ‡ BI = Bias Index (see Table 1 
footnote for interpretation). TIA = transient ischemic attack, CAD = coronary heart disease, AF = atrial fibrillation, DVT = deep vein thrombosis.
Table 5: Inter-rater reliability for discharge related data.
Variable (Item Number) Dichotomous response option N PI* Kappa (95% LCL)† BI‡
Discharge destination (12.3) Home (routine) 104 -0.22 0.38 (0.23) 0.26
Skilled nursing facility 104 -0.88 0.00 0.13
Rehabilitation 104 -0.78 0.30 (0.23) 0.14
Ambulatory status at discharge (12.5) Yes – Independent 104 0.19 0.52 (0.36) 0.04
Yes – With assistance 104 -0.64 0.19 (-0.03) -0.09
No – Unable 104 -0.71 0.69 (0.49) 0.02
On lipid lowering medication at D/C (12.11) Yes 104 -0.35 0.78 (0.65) 0.04
On diabetes medication at D/C (12.13) Yes 104 -0.55 0.86 (0.75) 0.03
On anti-hypertensive medication at D/C (12.16) Yes 104 -0.44 0.78 (0.59) -0.02
On anti-thrombotic therapy at D/C (12.20) Yes – Aspirin 104 -0.17 0.76 (0.64) -0.02
Yes – Warfarin 104 -0.58 0.94 (0.86) 0.00
None given 104 -0.60 0.76 (0.60) -0.02
* PI = Prevalence Index (see Table 1 footnote for interpretation). † 95% LCL = 95% Lower Confidence Limit. ‡ BI = Bias Index (see Table 1 
footnote for interpretation). D/C = discharge, skilled nursing facility = nursing home.BMC Neurology 2008, 8:19 http://www.biomedcentral.com/1471-2377/8/19
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(19/104) of subjects, while brain imaging time was
recorded by both abstractors in only 29% (30/104) of
subjects. Similar to our findings, the previous study [13]
that examined data quality in the context of the PCNASR
also found that time-related events, particularly those
associated with pre-hospital and ED environments, were
the most likely to be missing.
Another problem area was the recording of the onset time
of stroke symptoms which is another critical data point in
determining eligibility for acute thrombolytic therapy. In
the PCNASR information on stroke onset time is recorded
in terms of whether the onset of symptoms is known to be
specific (i.e., known precisely), or estimated (i.e., known
to have occurred within a 6 hour window), or unknown.
This data element had significant problems with both low
reliability and substantial bias, particularly for the 'esti-
mated time' response option. Similarly, the recording of
the source of the stroke onset time data – whether the
information was provided by a witness, by self report, or
was not documented was also problematic in terms of
poor reliability and bias. We have previously reported
wide variability in the documentation of onset time
between PCNASR prototypes, which implies problems
with the recording of this information in the charts [2].
Other studies examining stroke onset time data have
found a similar high degree of missingness or inaccurate
data, particularly when the data is abstracted retrospec-
tively from medical charts [26,27]. The study by Evenson
et al [26] found that information on the time of symptom
onset was more complete if collected by face-to-face inter-
view (95%) than by medical record abstraction (60%),.
Given the central importance of recording stroke onset
time accurately, our findings suggest the need to modify
the original definitions so that they are more precise and
unambiguous. An approach to the documentation of
stroke onset time that addresses these issues has been
recently proposed by Rosamond [28], who recommends
the development of a real-time data collection system to
record symptom onset time data for all patients evaluated
with stroke-like symptoms in the ED. The accuracy of
onset time data can also be improved by the use of stand-
ardized definitions, in particular, the adoption of a fifteen
minute window for the designation of a specific onset
time [28]. Subsequent revisions to the PCNASR data ele-
ments have attempted to clarify the recording of stroke
onset time information [16] (see Additional file 2: Cur-
rent PCNASR data elements_2007.pdf), however the
instructions remain inherently complex and the reliability
of this critically important data item remains in question.
Poor reliability of medical chart data can be attributed to
a combination of factors including ambiguous or compli-
cated data definitions, inadequate training, and/or prob-
lems accessing information from the charts [29-31]. The
use of bias index (BI) in this study helps identify system-
atic differences between the hospital abstractors and the
audit rater, which can imply either differences in the inter-
pretation of the data elements or differences in access to
specific information. Ambiguous or complicated data def-
initions likely contributed to the poor reliability and rater
bias associated with two variables; date and time of stroke
team consultation and DVT prophylaxis. Discussions
which followed the completion of this study found that
there was wide variability between hospital abstractors in
their understanding of the definition of an acute stroke
team; in the PCNASR a stroke team is broadly defined to
include any medical personnel (i.e., physician, nurse,
physician assistant) who evaluated the patient for throm-
bolytic (tPA) therapy in the ED. Due in part to the poor
reliability of this data element, stroke team consultation is
no longer included in the current registry data elements.
The poor reliability and bias associated with DVT proph-
ylaxis stemmed from the difficulty in determining who
was eligible for this measure; patients who are ambulating
by the second hospital day are not eligible for this inter-
vention. However, at the time of this study, instructions
on how to define ambulatory status for hospitalized
patients were lacking. The current version of the registry
data elements now includes a separate variable to docu-
ment ambulatory status (defined as 'walking 50 feet inde-
pendently or out of bed to bathroom without
supervision') [16] (see Additional file 2: Current PCNASR
data elements_2007.pdf).
Some of our results suggest that the reliability of certain
data elements was impacted by the fact that hospital
abstractors had access to information that was not availa-
ble to the audit abstractor. For example, the observed bias
for hospital abstractors to have rated race as white (BI =
0.13), while the audit rater tended to use race 'Not docu-
mented' (BI = -0.11), suggests that hospital abstractors
were more likely to assign race based on bedside observa-
tion. Gomez et al[32] reported that in a sample of 70 Cal-
ifornia hospitals approximately one-half obtained data on
race by observing a patient's physical appearance, and this
data is not consistently recorded in the medical chart. The
reliability and accuracy of race data would be improved if
hospitals included race as a specific item in the medical
chart, and if it were ascertained by patient self-report
rather than external observation.
The findings from this and other studies [13] can be used
to improve the reliability of the PCNASR data elements
through a combination of steps, including modifying data
elements, enhancing the clarity of data definitions, and
improving abstractor training. As discussed above several
data elements – stroke onset time, stroke team consulta-
tion and DVT prophylaxis, have already undergone signif-
icant changes in terms of either their structure, and/orBMC Neurology 2008, 8:19 http://www.biomedcentral.com/1471-2377/8/19
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instructions [16]. Given that many of the items with poor
reliability are collected in the ED environment (e.g.,
stroke team consult, onset time, brain imaging time), the
development of ED-based systems to capture data items in
real-time should be a major priority. Such systems could
be as simple as the consistent documentation by ED med-
ical staff of specific data elements included in an ED clin-
ical pathway, or as sophisticated as an electronic data
collection system that would record these data items in
real-time [33].
This study has several limitations. First, we had insuffi-
cient resources to abstract an adequate number of charts
to measure inter-rater reliability at the level of each hospi-
tal. Second, the fact that the data collected by the hospital
abstractors was assembled through a combination of pro-
spective (i.e., real-time) and retrospective (i.e., chart
abstraction) methods, whereas the audit abstractor had to
rely on only retrospective chart abstraction, likely
increased the frequency of discrepancies between the two
abstractors. Several instances where the reliability of spe-
cific data elements was affected by the lack of access to
data for the audit rater have already been highlighted. A
third limitation is the fact that charts were unavailable for
13 patients (11%) of the original sample. However, these
patients were randomly distributed across the 15 registry
hospitals and so this is unlikely to bias the results in any
significant way. Finally, while the inter-rater reliability for
these data elements may vary across other hospitals and
registries, the overall generalizability of these findings is
likely to be considerable, particularly for those items that
showed obvious problems with either ambiguous or com-
plicated data definitions, or a high degree of missingness.
Conclusion
The excellent inter-reliability of many of the data items
included in the PCNASR, such as demographics, stroke
subtype, past medical history, and discharge medications
supports use of the registry data for construction of per-
formance measures used to monitor care and guide QI ini-
tiatives. However, the poor reliability observed for some
variables, particularly the documentation of event times
will likely hinder the registry's ability to accurately moni-
tor care. Our findings illustrate specific areas, such as the
documentation of stroke onset time, where changes to
data definitions, enhanced abstractor training, and the
development of concurrent, real-time data collection sys-
tems should be strongly considered in order to improve
the quality of that data used to track and monitor acute
stroke care.
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